The separation in ovarian cancer among patient groups was observed to be statistically significant (log-rank test p = 0.034), while there was no statistically significant difference in survival among patients with BRCA1/2 mutation and no mutations in breast cancer (log-rank test p = 0.85) (Figure 4). This evidence concerns the gene BRCA1 and ovarian carcinoma.